ALIROCUMAB for Type v hyperlipidaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 902 adverse event reports in the FDA FAERS database where ALIROCUMAB was used for Type v hyperlipidaemia.
Most Reported Side Effects for ALIROCUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 1,571 | 6.9% | 1 | 79 |
| Product dose omission | 1,354 | 5.9% | 1 | 63 |
| Injection site pain | 1,220 | 5.3% | 4 | 34 |
| Muscle spasms | 1,113 | 4.9% | 2 | 35 |
| Arthralgia | 993 | 4.3% | 3 | 50 |
| Fatigue | 922 | 4.0% | 6 | 69 |
| Pain | 892 | 3.9% | 2 | 76 |
| Pain in extremity | 888 | 3.9% | 1 | 58 |
| Product dose omission issue | 864 | 3.8% | 0 | 30 |
| Injection site bruising | 821 | 3.6% | 2 | 26 |
| Device issue | 785 | 3.4% | 0 | 23 |
| Influenza like illness | 778 | 3.4% | 0 | 23 |
| Diarrhoea | 738 | 3.2% | 1 | 82 |
| Headache | 718 | 3.1% | 1 | 61 |
| Injection site erythema | 679 | 3.0% | 0 | 25 |
Other Indications for ALIROCUMAB
Hypercholesterolaemia (4,924)
Hyperlipidaemia (3,317)
Blood cholesterol increased (2,246)
Type iia hyperlipidaemia (1,913)
Product used for unknown indication (1,704)
Blood cholesterol (1,299)
Arteriosclerosis (417)
Blood cholesterol abnormal (345)
Low density lipoprotein increased (326)
Arteriosclerosis coronary artery (145)
Other Drugs Used for Type v hyperlipidaemia
EVOLOCUMAB (1,816)
ATORVASTATIN (72)
ROSUVASTATIN (44)
SIMVASTATIN (23)
EZETIMIBE (21)
INCLISIRAN (20)
FENOFIBRATE (16)
PITAVASTATIN (12)
DUPILUMAB (11)
BEMPEDOIC ACID (7)